StockData
Immunome Inc. logo

Immunome Inc. (IMNM) stock

IMNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$18.77+0.07 (+0.37%)

Close on Nov 13, 2026Market cap $2.13BP/E –Yield –

Immunome statistics

72 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Mar 2, 2027 (estimated, after the close)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$2.13B
$272.32M
Enterprise Value
$1.67B
$146.23M
PS Ratio
530.97
3.66
PB Ratio
4.69
2.00
P/TBV Ratio
4.69
2.22

Enterprise valuationIndustry

EV / Sales
416.01
2.57

Share statisticsIndustry

Shares Change (YoY)
46.0%
10.8%
Float
106M
49M
Shares Held by Insiders
6.45%
11.7%
Shares Held by Institutions
103.9%
56.4%

Short sellingIndustry

Short Interest
16M
–
Short Interest Change
-6.41%
-0.80%
Short % of Float
15.2%
9.01%
Short % of Shares Outstanding
14.2%
6.30%
Days to Cover
12.77
5.15

Stock price statisticsIndustry

52-Week High
$30.06
–
52-Week Low
$16.11
–
20-Day Moving Average
$18.57
–
50-Day Moving Average
$20.65
–
200-Day Moving Average
$22.21
–
Average True Range (14)
$1.25
–
Price Change (1 Week)
0.32%
-1.15%
Price Change (1 Month)
7.87%
-4.87%
Price Change (3 Months)
-31.5%
-21.0%
Price Change (6 Months)
-10.1%
-20.6%
Price Change (YTD)
-12.6%
-23.6%
Price Change (1 Year)
7.69%
-22.4%
Price Change (3 Years)
134.0%
-29.5%
Price Change (5 Years)
3.53%
-77.9%
Average Volume (10 Days)
2M
–
Average Volume (20 Days)
2M
–
Average Volume (90 Days)
1M
–
Relative Volume
0.74
0.70
Relative Strength Index (14)
46.9
43.4
Volatility (1 Year)
60.8%
80.1%
Beta (5 Years)
1.74
1.07

MarginsIndustry

Operating Margin
-5947.9%
-38.7%
Profit Margin
-5593.8%
-31.6%
EBITDA Margin
-5886.7%
-27.7%
FCF Margin
-5118.9%
-9.56%

Returns on capitalIndustry

Return on Equity (ROE)
-62.5%
-49.9%
Return on Assets (ROA)
-55.8%
-40.6%
Return on Capital Employed (ROCE)
-51.4%
-37.9%

Financial positionIndustry

Current Ratio
11.66
3.30
Quick Ratio
11.27
2.39

GrowthIndustry

Revenue Growth (YoY)
-63.3%
6.82%

EfficiencyIndustry

Asset Turnover
0.01
0.40
Revenue Per Employee
$22.68K
$429.29K
Profits Per Employee
-$1.27M
-$689.41K
Employee Count
177
74
WACC
13.8%
10.2%

Income statement (TTM)Industry

Revenue
$4.02M
$66.37M
Operating Income
-$238.81M
-$21.37M
Net Income
-$224.59M
-$22.35M
EBITDA
-$236.35M
-$17.21M
EPS (Diluted)
-$2.37
-$0.76

Balance sheetIndustry

Net Cash (Debt)
$461.58M
$17.76M
Net Cash Per Share
$4.06
$0.80
Equity (Book Value)
$454.30M
$53.89M
Book Value Per Share
$4.00
$1.50
Tangible Book Value
$454.30M
$27.13M
Working Capital
$436.83M
$79.99M

Cash flow (TTM)Industry

Operating Cash Flow
-$196.50M
-$12.38M
Capital Expenditures
-$9.02M
-$1.00M
Free Cash Flow
-$205.52M
-$18.21M
FCF Per Share
-$1.81
-$0.42

Dividends and yieldsIndustry

Earnings Yield
-10.5%
-21.8%
FCF Yield
-9.64%
-9.44%

Scores and fair valueIndustry

Altman Z-Score
21.85
0.23
Piotroski F-Score
4
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodIMNMS&P 500DifferenceIMNM per yearS&P 500 per year
1 month+6.8%-3.0%+9.8 pts
3 months-29.0%-2.8%−26.2 pts
Year to date-12.6%+11.5%−24.1 pts
1 year+13.7%+13.5%+0.2 pts
3 years+127.8%+77.7%+50.1 pts+31.6%+21.1%
5 years+3.5%+72.6%−69.1 pts+0.7%+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

16M IMNM shares were sold short on Oct 30, 2026, down 6.4% from the previous report, or 15.22% of the shares available to trade. At recent volumes it would take 12.8 days to buy them back. Over the last 20 sessions, 66.8% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202616,173,694-6.4%1,266,44712.8
Oct 15, 202617,281,614+3.1%1,421,72312.2
Sep 30, 202616,757,287+3.2%1,691,3679.9
Sep 15, 202616,244,557+3.9%787,59820.6
Aug 31, 202615,634,596-10.1%1,236,75712.6
Aug 14, 202617,392,529-3.3%1,165,02114.9
Jul 31, 202617,981,724+4.3%782,63823.0
Jul 15, 202617,237,765-0.7%1,635,31710.5
Jun 30, 202617,366,167-4.3%2,139,3198.1
Jun 15, 202618,148,499+7.6%1,403,49412.9
May 29, 202616,863,159-4.4%1,190,67514.2
May 15, 202617,630,541-5.5%878,98720.1

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?